Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Artigo em Francês | MEDLINE | ID: mdl-25011203

RESUMO

Percutaneous aortic valve replacement (TAVI) is one of the most innovative procedure in interventional cardiology. The Direct Flow Medical transcatheter aortic valve (DFM) is a new nonmetallic valve which allows perfect repositioning and valve retrieval prior to the final deployment. This study is a prospective non-randomized evaluation of the DFM system in the Luxembourg registry. The study focused on 15 patients who received between March 2013 and October 2013 a percutaneous aortic valve replacement by DFM prosthesis. All clinical and echocardiographic data have been collected prospectively. Fifteen inoperable patients with severe aortic stenosis were evaluated. The average age of our population was 83 +/- 4.16 years, mean STS score was 16%. 46% of patients were in NYHA class III and 33.3% in NYHA class IV. Mean ejection fraction was 59% +/- 12.7, the average mean gradient was 52.86 +/- 18.5 mm Hg and mean aortic orifie was 0.63 +/- 0.15 cm2. Procedural success rate was 100%. The mean trans- valvular gradient decreased from 52.86 +/- 18.5 mm Hg to 12 +/- 4.2 mm Hg (p < 0.001). The average hospital stay was 14 +/- 7.6 days. The non-fatal major event rate at one month was 33.3%. The mortality rate at one month was limited to 6.6%. These results allow us to confirm the efficacy and safety of the DFM valve.


Assuntos
Estenose da Valva Aórtica/cirurgia , Valva Aórtica/cirurgia , Implante de Prótese de Valva Cardíaca/métodos , Próteses Valvulares Cardíacas , Idoso , Idoso de 80 Anos ou mais , Estenose da Valva Aórtica/diagnóstico por imagem , Humanos , Luxemburgo , Complicações Pós-Operatórias , Estudos Prospectivos , Sistema de Registros , Resultado do Tratamento , Ultrassonografia
2.
Ann Cardiol Angeiol (Paris) ; 60(3): 141-7, 2011 Jun.
Artigo em Francês | MEDLINE | ID: mdl-20708725

RESUMO

Supraventricular tachycardia in infants are variable. We try to summarize clinical, electrical and treatment particularities of supraventricular arrhythmia in infants. The majority of infants with supraventricular arrhythmia have a good clinical outcome and an excellent prognosis and may not require chronic antiarrhythmic therapy if they had precocious treatment.


Assuntos
Taquicardia Supraventricular/terapia , Algoritmos , Amiodarona/uso terapêutico , Antiarrítmicos/uso terapêutico , Flutter Atrial/congênito , Flutter Atrial/diagnóstico , Flutter Atrial/terapia , Ablação por Cateter , Técnicas de Apoio para a Decisão , Cardioversão Elétrica , Eletrocardiografia , Feminino , Seguimentos , Humanos , Lactente , Recém-Nascido , Masculino , Processamento de Sinais Assistido por Computador , Taquicardia Supraventricular/congênito , Taquicardia Supraventricular/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...